Skip to main content

Diagnostic options · UAE

Histology tests in Dubai & UAE

Compare available Histology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

107

Listed price range

450.00–15,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Histology test prices

Showing 91–105 of 107 matching tests.

Histology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1893
Myogenin Immunohistochemistry (IHC) Test

This diagnostic test evaluates the presence of myogenin protein in tumor tissue to confirm rhabdomyosarcoma and determine its subtype.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Archival Specimen 5 working days (expedited 3-day option available) 550.00 AED
View
View test specifications and preparation
What it measures
["Myogenin protein expression", "Skeletal muscle differentiation"]
Parameters
[]
Preparation
[]
Indications
["Suspected rhabdomyosarcoma", "Need for rhabdomyosarcoma subtyping (embryonal vs. alveolar)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94497-8 ICD-10: C49.9
Clinical summary
This diagnostic test evaluates the presence of myogenin protein in tumor tissue to confirm rhabdomyosarcoma and determine its subtype.
TEST-2265
Napsin A Immunohistochemistry Test

This diagnostic test evaluates tumor tissue for the presence of the Napsin A protein to aid in the diagnosis of primary lung adenocarcinoma.

Formalin-fixed paraffin-embedded (FFPE) tumor tissue block or biopsy slides 5–7 working days 450.00 AED
View
View test specifications and preparation
What it measures
["Napsin A protein expression"]
Parameters
[]
Preparation
[]
Indications
["Suspected primary lung adenocarcinoma", "Differentiation from metastatic carcinoma"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94471-8 ICD-10: C34.9
Clinical summary
This diagnostic test evaluates tumor tissue for the presence of the Napsin A protein to aid in the diagnosis of primary lung adenocarcinoma.
TEST-1792
Olig2 Immunohistochemistry (IHC) Test

This diagnostic test evaluates the presence and expression level of the Olig2 protein in tumor tissue samples.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Histopathology Slides 5–7 business days 550.00 AED
View
View test specifications and preparation
What it measures
["Oligodendrocyte transcription factor 2 protein expression"]
Parameters
[]
Preparation
["No special preparation required", "Provide histopathology report, biopsy details, and clinical history"]
Indications
["Classification of gliomas", "Diagnosis of oligodendroglioma", "Guiding targeted therapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94482-6 ICD-10: C71.9
Clinical summary
This diagnostic test evaluates the presence and expression level of the Olig2 protein in tumor tissue samples.
TEST-2070
OLIG2 Immunohistochemistry Test

This diagnostic test evaluates the presence and expression level of the OLIG2 protein within tumor tissue.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Fresh Biopsy in 10% formal-saline 5 – 7 business days 550.00 AED
View
View test specifications and preparation
What it measures
["OLIG2 protein expression", "Oligodendrocyte transcription factor 2"]
Parameters
[]
Preparation
[]
Indications
["Suspected oligodendroglioma", "Differentiation of glial tumors", "Guiding neuro-oncology treatment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21952-8 ICD-10: C71.9
Clinical summary
This diagnostic test evaluates the presence and expression level of the OLIG2 protein within tumor tissue.
TEST-2823
OncoPro NCCN Lung Cancer Panel Test

This test evaluates genomic alterations in 15+ NCCN-recommended genes relevant to lung cancer.

20 mL Whole Blood in two Streck tubes 35 working days 13,000.00 AED
View
View test specifications and preparation
What it measures
["Genomic alterations (mutations, amplifications, deletions)", "Tumor Mutational Burden (TMB)", "Microsatellite Instability (MSI)", "Drug-sensitivity annotations"]
Parameters
[]
Preparation
["No fasting required.", "Inform the team of any anticoagulant therapy."]
Indications
["Diagnosis of lung cancer", "Treatment planning for lung cancer", "Monitoring for resistance mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96984-7 ICD-10: C34.9, Z85.1
Clinical summary
This test evaluates genomic alterations in 15+ NCCN-recommended genes relevant to lung cancer.
TEST-49
OncoPro NCCN Lung Cancer Panel with PD-L1 Test

This test evaluates clinically relevant genetic alterations and PD-L1 expression in lung cancer using a liquid biopsy.

Blood (Liquid Biopsy) 35 working days from sample receipt 15,600.00 AED
View
View test specifications and preparation
What it measures
["Genetic alterations (mutations, amplifications, etc.)", "PD-L1 expression"]
Parameters
[]
Preparation
["No fasting or special dietary preparation is needed.", "Mandatory completion of the OncoPro Liquid Biopsy Clinical Information Form (Form 32) is required prior to sample collection."]
Indications
["Diagnosis of lung cancer", "Guiding targeted therapy selection", "Guiding immunotherapy selection", "Monitoring treatment response (potential)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91847-7 ICD-10: C34.90
Clinical summary
This test evaluates clinically relevant genetic alterations and PD-L1 expression in lung cancer using a liquid biopsy.
TEST-2792
ONCOPRO® LUNG BASIC PANEL Test

This diagnostic test evaluates key genetic mutations (EGFR, KRAS, ALK, ROS1) in lung cancer tissue to guide targeted therapy.

Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block – Archival Specimen 3 Business Days (Mon/Thu collection, Fri/Tue report) 1,600.00 AED
View
View test specifications and preparation
What it measures
["EGFR mutations", "KRAS mutations", "ALK rearrangements", "ROS1 mutations"]
Parameters
[]
Preparation
["No special fasting or medication adjustments are needed prior to tissue collection."]
Indications
["Newly diagnosed non-small cell lung cancer (NSCLC)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21631-8 ICD-10: C34.90
Clinical summary
This diagnostic test evaluates key genetic mutations (EGFR, KRAS, ALK, ROS1) in lung cancer tissue to guide targeted therapy.
TEST-2075
p40 (ΔNp63) Immunohistochemistry Test

This test identifies the ΔNp63 isoform of p40 protein in tissue samples to differentiate squamous cell carcinoma from adenocarcinoma.

Archival Tissue Specimen (FFPE block or unstained slides) 5–7 business days 480.00 AED
View
View test specifications and preparation
What it measures
["ΔNp63 isoform of p40 protein"]
Parameters
[]
Preparation
["No patient preparation is required."]
Indications
["Differentiation of squamous cell carcinoma from adenocarcinoma", "Lung cancer subtyping", "Head/neck tumor diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83077-8 ICD-10: C34.90, C34.1, Z15.09
Clinical summary
This test identifies the ΔNp63 isoform of p40 protein in tissue samples to differentiate squamous cell carcinoma from adenocarcinoma.
TEST-2052
PAX-8 Immunohistochemistry (IHC) Test

This test identifies the presence of the PAX-8 protein in tumor tissue, aiding in the classification of certain cancers.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block 5–7 working days from FFPE block receipt 550.00 AED
View
View test specifications and preparation
What it measures
["PAX-8 protein expression"]
Parameters
[]
Preparation
[]
Indications
["Suspected ovarian, renal, thyroid, or Müllerian system malignancy", "Distinguishing primary site origins in metastatic disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95896-8 ICD-10: C80.1
Clinical summary
This test identifies the presence of the PAX-8 protein in tumor tissue, aiding in the classification of certain cancers.
TEST-2081
PD-1 Immunohistochemistry Test

This diagnostic test evaluates the expression level of the PD-1 protein within tumor tissue.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Biopsy Slides 5 to 7 working days 950.00 AED
View
View test specifications and preparation
What it measures
["PD-1 protein expression", "Tumor-infiltrating lymphocyte PD-1 expression", "Tumor cell PD-1 expression"]
Parameters
[]
Preparation
["No specific patient preparation is needed."]
Indications
["Guiding immunotherapy decisions", "Personalizing cancer treatment plans", "Monitoring immunotherapy efficacy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94691-7 ICD-10: Z85.9
Clinical summary
This diagnostic test evaluates the expression level of the PD-1 protein within tumor tissue.
TEST-1244
PD-L1 (SP263) Immunohistochemistry Test

This test evaluates the expression level of the PD-L1 protein on tumor cells within a tissue sample.

FFPE block or formalin-fixed tissue 5 working days (block), 7 days large complex 1,200.00 AED
View
View test specifications and preparation
What it measures
["PD-L1 protein expression", "Tumor Proportion Score (TPS)"]
Parameters
[{"name": "Tumor Proportion Score (TPS)", "reference_range": null}]
Preparation
[]
Indications
["Non-small cell lung cancer", "Urothelial carcinoma", "Other malignancies where immunotherapy is considered"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 102645-9 ICD-10: C34.9, Z51.12
Clinical summary
This test evaluates the expression level of the PD-L1 protein on tumor cells within a tissue sample.
TEST-2057
PD-L1 SP142 Immunohistochemistry Test

This test evaluates the expression of PD-L1 protein on tumor and immune cells using immunohistochemistry.

FFPE tissue block or biopsy slide (Archival Solid Tissue) 5–7 working days 1,500.00 AED
View
View test specifications and preparation
What it measures
["PD-L1 expression on tumor cells (TC)", "PD-L1 expression on tumor-infiltrating immune cells (IC)"]
Parameters
[]
Preparation
["No special patient preparation is needed.", "Arrange for a fresh tumor biopsy or FFPE block.", "Provide a copy of your histopathology report.", "Note your biopsy site and relevant clinical history."]
Indications
["Predicting response to atezolizumab immunotherapy", "Guiding treatment in non-small cell lung cancer", "Guiding treatment in urothelial carcinoma", "Guiding treatment in triple-negative breast cancer"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90512-7 ICD-10: Z85.118
Clinical summary
This test evaluates the expression of PD-L1 protein on tumor and immune cells using immunohistochemistry.
TEST-1234
PD‑L1 (Dako 22C3) Immunohistochemistry Test

This test evaluates the expression level of the PD-L1 protein on tumour cells within a formalin-fixed paraffin-embedded tissue sample.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block 7–8 working days 3,500.00 AED
View
View test specifications and preparation
What it measures
["PD-L1 protein expression", "Tumour Proportion Score (TPS)"]
Parameters
[{"name": "Tumour Proportion Score (TPS)", "reference_range": "Reported as a percentage (0-100%)"}]
Preparation
[]
Indications
["Determining eligibility for immune checkpoint inhibitor therapy", "Guiding treatment decisions in non-small cell lung cancer and other solid tumours"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88210-9 ICD-10: C80.1, Z51.12, Z85.3
Clinical summary
This test evaluates the expression level of the PD-L1 protein on tumour cells within a formalin-fixed paraffin-embedded tissue sample.
TEST-1934
ROS1 Immunohistochemistry (IHC) Test

This diagnostic test evaluates for the presence and level of ROS1 protein expression in tumor tissue samples.

FFPE block or tumor tissue in 10% formal-saline 5-7 working days 900.00 AED
View
View test specifications and preparation
What it measures
["ROS1 protein overexpression", "Immunohistochemical staining"]
Parameters
[]
Preparation
["No dietary restrictions", "No medication changes", "No fasting required"]
Indications
["Non-small cell lung cancer (NSCLC) screening", "Identification of patients eligible for targeted therapy (crizotinib, entrectinib)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 19049-2 ICD-10: C34.90
Clinical summary
This diagnostic test evaluates for the presence and level of ROS1 protein expression in tumor tissue samples.
TEST-1917
Test 1329

This diagnostic test evaluates the presence and localization of Alpha-Fetoprotein (AFP) protein expression within tumour tissue.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block 5–7 Business Days 550.00 AED
View
View test specifications and preparation
What it measures
["Alpha-Fetoprotein (AFP) protein expression", "Tumour cell differentiation"]
Parameters
[{"name": "AFP Expression", "reference_range": "Positive/Negative (Qualitative)"}]
Preparation
["No special patient preparation is needed.", "Ensure managing physician provides complete histopathology report, biopsy site details, and clinical history."]
Indications
["Confirmation of hepatocellular carcinoma", "Subtyping of gonadal tumours", "Guiding treatment decisions for liver or germ cell cancers"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31998-0 ICD-10: C22.0
Clinical summary
This diagnostic test evaluates the presence and localization of Alpha-Fetoprotein (AFP) protein expression within tumour tissue.

Category overview

Histology: overview

Gaining clarity at the microscopic level is a critical step in accurately identifying the root causes of underlying health concerns. At DNA Labs UAE, our Histology services provide meticulous tissue examinations using advanced staining techniques and high-resolution microscopy. This in-depth histological testing in the UAE equips your healthcare provider with the precise structural details necessary to guide their clinical decision-making and patient care. As one of the most respected diagnostic labs in Dubai/UAE, we are dedicated to providing fast, pinpoint-accurate turnaround times while safeguarding your sensitive health information with strict confidentiality. Move forward with confidence. Explore our histology diagnostic services, coordinate a sample collection with your physician, or contact our specialists for more information.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area